Glucocorticoid receptor in astrocytes regulates midbrain dopamine neurodegeneration through connexin hemichannel activity.
Journal
Cell death and differentiation
ISSN: 1476-5403
Titre abrégé: Cell Death Differ
Pays: England
ID NLM: 9437445
Informations de publication
Date de publication:
03 2019
03 2019
Historique:
received:
14
12
2017
accepted:
28
05
2018
revised:
20
05
2018
pubmed:
15
7
2018
medline:
4
6
2020
entrez:
15
7
2018
Statut:
ppublish
Résumé
The precise contribution of astrocytes in neuroinflammatory process occurring in Parkinson's disease (PD) is not well characterized. In this study, using GR
Identifiants
pubmed: 30006609
doi: 10.1038/s41418-018-0150-3
pii: 10.1038/s41418-018-0150-3
pmc: PMC6370798
doi:
Substances chimiques
Connexins
0
GJE1 protein, human
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
580-596Références
Lancet Neurol. 2009 Apr;8(4):382-97
pubmed: 19296921
Ann Neurol. 2005 Feb;57(2):168-75
pubmed: 15668962
Lancet. 2009 May 30;373(9678):1905-17
pubmed: 19482216
Front Cell Neurosci. 2014 Oct 21;8:306
pubmed: 25374505
Mov Disord. 2013 Jan;28(1):24-30
pubmed: 22927094
Glia. 2008 Sep;56(12):1299-311
pubmed: 18512249
J Neuroimmunol. 2014 Apr 15;269(1-2):20-27
pubmed: 24534266
Nat Genet. 1999 Sep;23(1):99-103
pubmed: 10471508
Glia. 2007 Jan 1;55(1):104-17
pubmed: 17029244
FASEB J. 2009 Aug;23(8):2478-89
pubmed: 19276172
Cell Death Differ. 2013 Nov;20(11):1546-57
pubmed: 24013726
J Biol Chem. 2012 Apr 6;287(15):12250-66
pubmed: 22351781
Mol Cell Endocrinol. 2007 Sep 15;275(1-2):79-97
pubmed: 17561338
Blood. 2015 Nov 5;126(19):2202-12
pubmed: 26324703
Endocr Rev. 2003 Aug;24(4):488-522
pubmed: 12920152
Brain. 2012 Nov;135(Pt 11):3336-47
pubmed: 23169921
Nat Methods. 2004 Oct;1(1):31-7
pubmed: 15782150
Pharmacol Rev. 2017 Oct;69(4):396-478
pubmed: 28931622
Basic Res Cardiol. 2013 Jan;108(1):309
pubmed: 23184389
Glia. 2015 May;63(5):795-811
pubmed: 25643695
PLoS One. 2013 Nov 13;8(11):e79350
pubmed: 24236122
PLoS Biol. 2004 Apr;2(4):E96
pubmed: 15094801
Eur J Pharmacol. 2014 Feb 5;724:231-6
pubmed: 23747654
Neuroscience. 1993 Jan;52(1):1-6
pubmed: 8433802
Mov Disord. 2008 Mar 15;23(4):474-83
pubmed: 18044695
Proc Natl Acad Sci U S A. 2011 Apr 19;108(16):6632-7
pubmed: 21467220
J Neurosci. 2007 Dec 12;27(50):13781-92
pubmed: 18077690
Exp Neurol. 2006 Feb;197(2):275-83
pubmed: 16336966
Nat Rev Immunol. 2010 May;10(5):365-76
pubmed: 20414208
Curr Top Behav Neurosci. 2015;22:205-20
pubmed: 24850081
Transgenic Res. 2008 Oct;17(5):919-28
pubmed: 18483774
Genesis. 2007 Sep;45(9):593-605
pubmed: 17868096
CNS Neurol Disord Drug Targets. 2013 Dec;12(8):1175-93
pubmed: 24040816
Nat Rev Neurosci. 2015 May;16(5):249-63
pubmed: 25891508
J Neuropathol Exp Neurol. 2009 Oct;68(10):1073-83
pubmed: 19918119
Biochim Biophys Acta. 2014 Oct;1843(10):2211-32
pubmed: 24768716
Adv Immunol. 2010;106:21-59
pubmed: 20728023
Acta Neuropathol. 2000 Jan;99(1):14-20
pubmed: 10651022
Neurobiol Dis. 2014 Sep;69:76-92
pubmed: 24878508
BMC Genomics. 2014 Aug 06;15:656
pubmed: 25099603
Neuroscience. 2000;95(2):425-32
pubmed: 10658622
Basic Res Cardiol. 2012 Nov;107(6):304
pubmed: 23095853
Life Sci. 2011 Aug 1;89(5-6):141-6
pubmed: 21684291
PLoS One. 2012;7(11):e49398
pubmed: 23189143
Cell Death Differ. 2016 Oct;23(10):1691-701
pubmed: 27391799
Front Aging Neurosci. 2014 Sep 24;6:258
pubmed: 25309435
FASEB J. 2006 Oct;20(12):2000-8
pubmed: 17012252
Brain Res Rev. 2010 May;63(1-2):160-76
pubmed: 19963007
Nat Rev Neurosci. 2010 Feb;11(2):87-99
pubmed: 20087359
Front Pharmacol. 2013 Jul 17;4:88
pubmed: 23882216
Glia. 2007 Nov 15;55(15):1565-76
pubmed: 17823970
Acta Neuropathol. 2007 Sep;114(3):231-41
pubmed: 17576580